Santaris offers a Masters
Santaris Pharma is a biopharmaceutical company that develops innovative RNA-targeted medicines based on its proprietary locked nucleic acid (LNA) drug platform. The Company’s LNA oligonucleotide compounds are designed to effectively down-regulate disease-implicated mRNAs and microRNAs.
microRNAs are short non-coding RNAs that have been shown to be involved in the development of human diseases, such as cancer, CNS disorders and cardiovascular disease. We are currently working on targeting of microRNAs implicated in metabolic disorders. The primary objective of the Masters project will be to study selected miRNAs that play important roles in metabolic disease, such as atherosclerosis and dyslipidemia, using cell culture assays and LNA-antimiR oligonucleotides.
We offer: a dynamic and fun environment, good laboratory facilities, and an opportunity to use and develop your skills in an industrial setting. Great office space, lunch, fruit, coffee etc will be provided.
We expect: highly motivated and self-driven students with knowledge about cell culture and molecular biology techniques. We expect the student to be present and work regularly at our site in Hørsholm.
To apply: Please send an email to email@example.com or firstname.lastname@example.org, with your CV, information about yourself and your academic track record. We will be interviewing candidates for the project during August.